ENANTA PHARMACEUTICALS, INC (ENTA) Operating cash flow 2017–2025
ENANTA PHARMACEUTICALS, INC (ENTA) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$19.3MFY2025 · since FY2017: $52.7M → -$19.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$19.3M | +75.5% |
| FY2024 | -$78.8M | +23.6% |
| FY2023 | -$103.2M | -21.7% |
| FY2022 | -$84.8M | -21.1% |
| FY2021 | -$70.0M | -1087.5% |
| FY2020 | $7.1M | -90.1% |
| FY2019 | $71.4M | +144.4% |
| FY2018 | $29.2M | -44.5% |
| FY2017 | $52.7M | — |
Source: SEC XBRL filings · For reference only · Not investment advice